Status:
UNKNOWN
Correction of Hypernatremia by Intravenous Hypotonic Solution Compared to Enteral Water
Lead Sponsor:
Hospital Civil de Guadalajara
Conditions:
Hypernatremia
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Hypernatremia, defined as an elevation of serum sodium \>145 mEq/L, is one of the most common electrolyte disturbances in hospitalized patients and intensive care units. In this study, the investigat...
Detailed Description
Hypernatremia, defined as an elevation of serum sodium \>145 mEq/L, is one of the most common electrolyte disturbances in hospitalized patients and intensive care units, increasing mortality. Currentl...
Eligibility Criteria
Inclusion
- Hospitalized patients with hypernatremia (serum sodium\>145mEq/L).
Exclusion
- Age below 18 years
- Pregnant, on dialysis
- Unwilling to participate or without informed consent.
Key Trial Info
Start Date :
November 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2024
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT06061783
Start Date
November 30 2023
End Date
September 30 2024
Last Update
September 29 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.